Largest biotech by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Kodiak Sciences has the lowest figure of the 24 biotech ranked by total assets, at CZK 7.8B, followed by Scholar Rock Holding (CZK 9B) and ImmunityBio (CZK 11.2B). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Kodiak SciencesCZK 7.8B
- Median
- CZK 56.9B
- Combined market value
- CZK 18.72T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Kodiak SciencesKOD · Health Care | CZK 7.8B | CZK 140.9B | CZK 2,154.72 | 0.02% up | 396% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | CZK 9B | CZK 127.9B | CZK 1,048.21 | 4.48% up | 14% up | ||
| 3 | ImmunityBioIBRX · Health Care | CZK 11.2B | CZK 156.5B | CZK 147.10 | 5.59% up | 193% up | ||
| 4 | Adaptive BiotechnologiesADPT · Health Care | CZK 11.4B | CZK 101.8B | CZK 628.92 | 0.81% down | 88% up | ||
| 5 | Twist BioscienceTWST · Health Care | CZK 14.3B | CZK 175.6B | CZK 2,576.00 | 3.35% up | 340% up | ||
| 6 | CG OncologyCGON · Health Care | CZK 17.6B | CZK 158.9B | CZK 1,778.83 | 1.25% up | 85% up | ||
| 7 | ImmunovantIMVT · Health Care | CZK 21.3B | CZK 154.6B | CZK 747.10 | 1.08% up | 43% up | ||
| 8 | Krystal BiotechKRYS · Health Care | CZK 29.7B | CZK 204.5B | CZK 6,900.35 | 3.86% up | 46% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | CZK 38.8B | CZK 229.9B | CZK 2,692.62 | 0.44% down | 87% up | ||
| 10 | CRISPR TherapeuticsCRSP · Health Care | CZK 50.4B | CZK 90.3B | CZK 930.70 | 4.16% up | 21% down | ||
| 11 | Revolution MedicinesRVMD · Health Care | CZK 52.4B | CZK 773.5B | CZK 3,576.14 | 1.23% down | 131% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | CZK 56.2B | CZK 246.4B | CZK 2,161.06 | 1.18% up | 37% up | ||
| 13 | Bio-TechneTECH · Health Care | CZK 57.6B | CZK 254.3B | CZK 1,618.60 | 0.14% up | 26% up | ||
| 14 | ExelixisEXEL · Health Care | CZK 63.3B | CZK 375.6B | CZK 1,539.15 | 0.96% up | 63% up | ||
| 15 | RepligenRGEN · Health Care | CZK 65.6B | CZK 243.7B | CZK 3,811.60 | 5.60% up | 5% up | ||
| 16 | VaxcytePCVX · Health Care | CZK 66.8B | CZK 207.8B | CZK 1,312.82 | 0.69% down | 22% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | CZK 103.1B | CZK 366.8B | CZK 3,623.99 | 1.86% down | 20% up | ||
| 18 | QiagenQGEN · Health Care | CZK 139.8B | CZK 227.7B | CZK 1,102.62 | 0.41% down | 12% up | ||
| 19 | argenxARGX · Health Care | CZK 193.2B | CZK 1.32T | CZK 20,991.60 | 0.45% down | 4% up | ||
| 20 | ModernaMRNA · Health Care | CZK 274.6B | CZK 1.81T | CZK 4,485.15 | 2.55% down | 755% up | ||
| 21 | BioNTechBNTX · Health Care | CZK 542.9B | CZK 464.1B | CZK 1,871.75 | 0.89% down | 16% down | ||
| 22 | BiogenBIIB · Health Care | CZK 655.2B | CZK 822.2B | CZK 5,562.17 | 0.34% down | 49% up | ||
| 23 | Gilead SciencesGILD · Health Care | CZK 1.31T | CZK 4.68T | CZK 3,770.98 | 0.48% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | CZK 2.02T | CZK 5.38T | CZK 9,946.38 | 2.40% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2549 CZK).
Questions and answers
Which biotech have the lowest total assets?
Kodiak Sciences (CZK 7.8B), Scholar Rock Holding (CZK 9B) and ImmunityBio (CZK 11.2B) have the lowest total assets of the 24 biotech ranked here as of 18 Nov 2026, 16:31 UTC.
How many biotech are in this ranking?
24 are ranked by total assets.
What are these biotech worth together?
The 24 biotech ranked by total assets have a combined market value of CZK 18.72T as of 18 Nov 2026, 16:31 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.